BlackRock Amends AVNS Stake, Maintains Passive Position
Ticker: AVNS · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1606498
| Field | Detail |
|---|---|
| Company | Avanos Medical, INC. (AVNS) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns AVNS, signaling long-term confidence.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 22, 2024, indicating its ownership of AVANOS MEDICAL, INC. common stock as of December 31, 2023. This filing is an amendment (Amendment No: 2) to a previous filing, showing BlackRock continues to hold a significant, though passive, stake in Avanos Medical. This matters to investors because BlackRock is a major institutional investor, and their continued holding suggests a long-term, stable view of Avanos Medical's prospects, potentially signaling confidence in the company's future performance.
Why It Matters
This filing confirms BlackRock's ongoing, substantial, yet passive, investment in Avanos Medical, which can be seen as a vote of confidence from a major institutional investor.
Risk Assessment
Risk Level: low — This filing is routine for large institutional investors and indicates a stable, passive ownership, posing minimal immediate risk.
Analyst Insight
Investors should note BlackRock's continued passive ownership as a sign of institutional stability, but this filing alone doesn't suggest any immediate catalysts for stock movement. It's a routine update from a major holder.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- AVANOS MEDICAL, INC. (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the date the SC 13G/A was filed
- 05350V106 (other) — the CUSIP number for Avanos Medical's Common Stock
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Avanos Medical for the foreseeable future. (BlackRock Inc.) — high confidence, target: 12/31/2024
FAQ
What type of filing is this and who filed it?
This is an SC 13G/A filing, which is an amendment (Amendment No: 2) to a Schedule 13G, filed by BlackRock Inc. regarding its ownership in AVANOS MEDICAL, INC.
What is the purpose of an SC 13G/A filing?
An SC 13G/A is an amendment to a Schedule 13G, used by passive institutional investors (like BlackRock) to report their beneficial ownership of 5% or more of a company's stock, or to update previous filings if their ownership changes or if they are no longer eligible to file a 13G.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as stated in the filing.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' in the appropriate box on the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of AVANOS MEDICAL, INC. is 05350V106, as specified in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding AVANOS MEDICAL, INC. (AVNS).